Raises Xtant Medical FY 2026 Revenue Guidance to $101m-$105m as It Adds Hemoblast Distribution Rights
Earnings Call Insights: Xtant Medical Holdings (XTNT) Q1 2026 Management View - "Since our last quarterly update, Xtant Medical has achieved multiple significant milestones that position us for sustained growth," said President, CEO & Director Sean Browne, highlighting: "We...</p